A92-30641-72044
4 vaccinations
14 coded responses
37 check-ins
15 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 222 / VA
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Pfizer-BioNTech
-
2021-02-11
Survey response — day 0, dose 1MedDRA: Gastrointestinal disorder, Hypoaesthesia, Peripheral coldness, Pre-existing disease — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Cold, numbness in feet (diabetic). Feel hot inside stomach, intestine. (Chronic Kidney Disease).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
-
2021-02-15
Survey response — days 1–6 daily, dose 1MedDRA: Chronic kidney disease, Diabetes mellitus, Pre-existing disease — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Diabetic; chronic kidney disease.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 1MedDRA: Diabetes mellitus, Peripheral coldness, Pre-existing disease — Feeling: Good · Fatigue or tirednessFree text: Cold hands and feet. (Diabetic)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 1MedDRA: Feeling cold, Pre-existing disease — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Coldness all over. Diabetic.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-25
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-03-04
Survey response — day 0, dose 2MedDRA: Blood glucose increased, Diabetes mellitus — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Diabetic: elevated blood sugar.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased, Diabetes mellitus, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Diabetic: high blood sugar.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease, Vision blurred — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Diabetic, cataracts, glaucoma: increased blurred vision.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: Cataract, Diabetes mellitus, Glaucoma, Pre-existing disease, Vision blurred — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Diabetic, cataract, glaucoma: blurred vision.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-10
Survey response — days 1–6 daily, dose 2MedDRA: Diabetes mellitus — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Diabetic: elevated blood sugar.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Diabetic: elevated blood sugar.Adult check-in · check-in free text available
- 2021-03-19
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-06-05
Survey response — 3 months, dose 2MedDRA: Cataract, Glaucoma, Office visit, Ophthalmological examination, Vision blurred, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Mature Glaucoma and cataracts.More blurred, dark vision. · Healthcare visit (other): In office, comprehensive eye exam.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-05
Survey response — 6 months, dose 2MedDRA: Cataract, Glaucoma, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Mature glaucoma and Cataracts. · Healthcare visit (other): Doctors Office: In person.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-07
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-12
-
2021-10-16
Survey response — day 21, dose 3MedDRA: Cataract, Glaucoma — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe Glaucoma and Senile Cataracts.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-23
- 2021-10-30
-
2021-11-07
Survey response — day 42, dose 3MedDRA: Abdominal pain upper, Asthenia, Fatigue, Frequent bowel movements, Pollakiuria — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stomach pain. Frequent urge to urinate and bowel movement. Feeling tired and weak.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-27
-
2022-03-26
Survey response — 6 months, dose 3MedDRA: Open angle glaucoma — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Advanced open angle glaucoma. Severe Stage.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Dose 4 — Pfizer-BioNTech
- 2022-04-19
-
2022-04-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-22
- 2022-04-25
- 2022-05-03
- 2022-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-04-19 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Cold, numbness in feet (diabetic). Feel hot inside stomach, intestine. (Chronic Kidney Disease).
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Diabetic; chronic kidney disease.
Systemic reaction (other): Cold hands and feet. (Diabetic)
Systemic reaction (other): Coldness all over. Diabetic.
Release 5 — day 0, dose 2
Systemic reaction (other): Diabetic: elevated blood sugar.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Diabetic: high blood sugar.
Systemic reaction (other): Diabetic, cataracts, glaucoma: increased blurred vision.
Systemic reaction (other): Diabetic, cataract, glaucoma: blurred vision.
Systemic reaction (other): Diabetic: elevated blood sugar.
Release 8 — 3 months, dose 2
Symptoms: Mature Glaucoma and cataracts.More blurred, dark vision.
Healthcare visit (other): In office, comprehensive eye exam.
Release 9 — 6 months, dose 2
Symptoms: Mature glaucoma and Cataracts.
Healthcare visit (other): Doctors Office: In person.
Release 10 — day 21, dose 3
Symptoms: Severe Glaucoma and Senile Cataracts.
Release 10 — day 42, dose 3
Symptoms: Stomach pain. Frequent urge to urinate and bowel movement. Feeling tired and weak.
Release 11 — 6 months, dose 3
Symptoms: Advanced open angle glaucoma. Severe Stage.
Release 12 — day 7, dose 2
Systemic reaction (other): Diabetic: elevated blood sugar.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Ophthalmological examination | ○ | ✓ | ○ |
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Cataract | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Frequent bowel movements | · | · | ✓ |
| SD | Glaucoma | ✓ | ✓ | ✓ |
| SD | Open angle glaucoma | · | · | ✓ |
| SD | Pollakiuria | · | · | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SD | Visual impairment | ✓ | ✓ | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Cataract | ✓ | ✓ | ✓ |
| SRO | Chronic kidney disease | ✓ | ✓ | ✓ |
| SRO | Diabetes mellitus | ✓ | ✓ | ✓ |
| SRO | Feeling cold | ✓ | ✓ | ✓ |
| SRO | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SRO | Glaucoma | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | ○ | ○ | ○ |
| SRO | Peripheral coldness | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release